Cost-effectiveness of Biological Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Implications for Clinical Practice

Martijn Kuijper, Leander Buisman, Mieke Hazes, Angelique Weel

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)965-967
Number of pages3
JournalJournal of Rheumatology
Volume44
Issue number7
DOIs
Publication statusPublished - 2017

Cite this